These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4448061)

  • 1. Report on the sue of the Dalkon Shield intrauterine device.
    Sadovsky E; Yarkoni S; Anteby SO
    Contraception; 1974 Nov; 10(5):475-80. PubMed ID: 4448061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
    Mumford SD; Kessel E
    Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized comparative trial of the Gravigard, Latex Leaf, Dalkon Shield and Multiload Cu 250 IUDs.
    McCarthy TG; Chew SC; Lim SM; Cheng MC; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):228-32. PubMed ID: 3545173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An association between the Dalkon Shield and complicated pregnancies among women hospitalized for intrauterine contraceptive device--related disorders.
    Kahn HS; Tyler CW
    Am J Obstet Gynecol; 1976 May; 125(1):83-6. PubMed ID: 1275008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Copper-7 intrauterine device (Gravigard). Report of experience].
    Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
    Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate post-termination insertion of Copper 7 and Dalkon Shield intrauterine contraceptive devices.
    Newton J; Elias J; Johnson A
    J Obstet Gynaecol Br Commonw; 1974 May; 81(5):389-92. PubMed ID: 4832320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The experience with Dalkon shield in UCLA family planning clinic].
    Wang AC
    Nihon Funin Gakkai Zasshi; 1974 Jul; 19():248-53. PubMed ID: 12158546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative randomized study of the copper-T 200 and Dalkon Shield intrauterine devices.
    Spellacy WN; Birk SA; Gordon L
    Contraception; 1975 Oct; 12(4):453-63. PubMed ID: 1192734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of infections associated with the intrauterine contraceptive device in an isolated community.
    Mead PB; Beecham JB; Maeck JV
    Am J Obstet Gynecol; 1976 May; 125(1):79-82. PubMed ID: 1275017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postpartum and postabortal insertion of intrauterine contraceptive devices.
    Martorella LA; Esposito JM
    J Reprod Med; 1975 Apr; 14(4):178-81. PubMed ID: 1142352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pregnancies with intra-uterine devices in-situ (author's transl)].
    Obolensky W; Bucheli J
    Geburtshilfe Frauenheilkd; 1975 Aug; 35(8):632-9. PubMed ID: 1175906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early postpartum insertion of an intrauterine device.
    Emens JM; Gustafson RC; Jordan JA
    Fertil Contracept; 1978 Jul; 2(3):38-41. PubMed ID: 12260722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LEM device in an immediate postpartum contraception program.
    Apelo R; Ramos R; Thomas M
    Fertil Steril; 1976 May; 27(5):517-22. PubMed ID: 1278454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with the Dalkon Shield as a contraceptive device.
    Perlmutter JF
    Obstet Gynecol; 1974 Mar; 43(3):443-6. PubMed ID: 4814463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical study of a progesterone-releasing intrauterine contraceptive device.
    Brenner PF; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1975 Mar; 121(5):704-6. PubMed ID: 1115173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with the copper 7 intrauterine device in an adolescent population.
    Kulig JW; Rauh JL; Burket RL; Cabot HM; Brookman RR
    J Pediatr; 1980 Apr; 96(4):746-50. PubMed ID: 7359288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
    Ratsula K
    Contraception; 1987 Dec; 36(6):659-66. PubMed ID: 3128429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.